Review Article

A review on the effect of air pollution and exposure to PM, NO2 , O3 , SO2 , CO and heavy metals on viral respiratory infections

Abstract

The ambient air pollutants that have a major role in causing respiratory diseases are particulate matter, sulfur dioxide, nitrogen dioxide, ozone, carbon
monoxide, and heavy metals. In addition, respiratory infections, divided
into upper respiratory tract and lower respiratory tract infection, are most
commonly caused by viral agents. Thus, in light of the current COVID-19
pandemic, this review has focused on the association between exposure to
general air pollution including each of the mentioned air pollutants and viral
respiratory infections. The gathered evidence from the reviewed studies in
this article showed that most of these air pollutants have a positive correlation
with mortality, severity, transmission, inflammation, and incidence of different viral respiratory infections. Whereas, some studies found contradictory
results such as non-significant and negative connections between exposure
to air pollutants and viral respiratory infections, which are further discussed
in this text. Therefore, following the SARS-CoV-2 outbreak, these contradictions in the reported correlation between air pollution and different aspects
of viral respiratory infections must be thoroughly investigated and cleared.

1. Table EN. Criteria Air Pollutants| US EPA. EPA; 2020.
2. Organization WH. Air quality guidelines: global update
2005: particulate matter, ozone, nitrogen dioxide, and
sulfur dioxide: World Health Organization; 2006.
3. Dasaraju PV, Liu C. Infections of the respiratory system.
Medical Microbiology 4th edition: University of Texas
Medical Branch at Galveston; 1996.
4. Arbex MA, Santiago SL, Moyses EP, Pereira LA, Saldiva
PH, Braga ALF. Impact of urban air pollution on acute
upper respiratory tract infections. Advanced Topics in
Environmental Health and Air Pollution Case Studies.
2011;237-50.
5. Hajat S, Anderson H, Atkinson R, Haines A. Effects of
air pollution on general practitioner consultations for
upper respiratory diseases in London. Occupational and
environmental medicine. 2002;59(5):294-9.
6. Li Y, Xiao C, Li J, Tang J, Geng X, Cui L, et al. Association between air pollution and upper respiratory tract infection in hospital outpatients aged 0–14 years in Hefei,
China: a time series study. Public health. 2018;156:92-
100.
7. Nhung NTT, Amini H, Schindler C, Joss MK, Dien
TM, Probst-Hensch N, et al. Short-term association between ambient air pollution and pneumonia in children:
A systematic review and meta-analysis of time-series
and case-crossover studies. Environmental Pollution.
2017;230:1000-8.
8. Nhung NTT, Schindler C, Dien TM, Probst-Hensch N,
Perez L, Künzli N. Corrigendum to “Acute effects of
ambient air pollution on lower respiratory infections
in Hanoi children: An eight-year time series study”
[Environ. Int. 110 (2018) 139-148]. Environ Int.
2018;119:240.
9. Wong CM, Yang L, Thach TQ, Chau PYK, Chan KP,
Thomas GN, et al. Modification by influenza on health
effects of air pollution in Hong Kong. Environmental
health perspectives. 2009;117(2):248-53.
10. Su W, Wu X, Geng X, Zhao X, Liu Q, Liu T. The shortterm effects of air pollutants on influenza-like illness in
Jinan, China. BMC public health. 2019;19(1):1-12.
11. Kan HD, Chen B-H, Fu CW, Yu S-Z, Mu LN. Relationship between ambient air pollution and daily mortality
of SARS in Beijing. Biomed Environ Sci. 2005;18:1-4.
12. Cui Y, Zhang Z-F, Froines J, Zhao J, Wang H, Yu S-Z,
et al. Air pollution and case fatality of SARS in the
People’s Republic of China: an ecologic study. Environmental Health. 2003;2(1):1-5.
13. Marquès M, Rovira J, Nadal M, Domingo JL. Effects of
air pollution on the potential transmission and mortality
of COVID-19: A preliminary case-study in Tarragona
Province (Catalonia, Spain). Environmental Research.
2020;192:110315.
14. Yongjian Z, Jingu X, Fengming H, Liqing C. Association between short-term exposure to air pollution and
COVID-19 infection: Evidence from China. Science of
the total environment. 2020:138704.
15. Glencross DA, Ho T-R, Camiña N, Hawrylowicz CM,
Pfeffer PE. Air pollution and its effects on the immune system. Free Radical Biology and Medicine.
2020;151:56-68.
16. Romano S, Becagli S, Lucarelli F, Rispoli G, Perrone MR. Airborne bacteria structure and chemical
composition relationships in winter and spring PM10
samples over southeastern Italy. Sci Total Environ.
2020;730:138899.
17. Kim D, Chen Z, Zhou L-F, Huang S-X. Air pollutants
and early origins of respiratory diseases. Chronic diseases and translational medicine. 2018;4(2):75-94.
18. Dagher Z, Garçon G, Gosset P, Ledoux F, Surpateanu G, Courcot D, et al. Pro‐inflammatory effects of
Dunkerque city air pollution particulate matter 2.5 in
human epithelial lung cells (L132) in culture. Journal of Applied Toxicology: An International Journal.
2005;25(2):166-75.
19. Hammond G, Raddatz R, Gelskey D. Impact of atmospheric dispersion and transport of viral aerosols on the
epidemiology of influenza. Reviews of infectious diseases. 1989;11(3):494-7.
20. Bashir MF, Bilal BM, Komal B. Correlation between
environmental pollution indicators and COVID-19 pandemic: A brief study in Californian context. Environmental Research. 2020:109652.
21. Wang Q, Kwan M-P, Zhou K, Fan J, Wang Y, Zhan
D. The impacts of urbanization on fine particulate matter (PM2. 5) concentrations: Empirical evidence from
135 countries worldwide. Environmental Pollution.
2019;247:989-98.
22. Perrone M, Gualtieri M, Consonni V, Ferrero L, Sangiorgi G, Longhin E, et al. Particle size, chemical composition, seasons of the year and urban, rural or remote
site origins as determinants of biological effects of particulate matter on pulmonary cells. Environmental pollution. 2013;176:215-27.
23. Tao J, Gao J, Zhang L, Zhang R, Che H, Zhang Z, et
al. PM 2.5 pollution in a megacity of southwest China:
source apportionment and implication. Atmospheric
Chemistry & Physics. 2014;14(4).
24. Feng C, Li J, Sun W, Zhang Y, Wang Q. Impact of ambient fine particulate matter (PM 2.5) exposure on the
risk of influenza-like-illness: a time-series analysis in
Beijing, China. Environmental Health. 2016;15(1):17.
25. Zou B, Zheng Z, Wan N, Qiu Y, Wilson JG. An optimized spatial proximity model for fine particulate matter air pollution exposure assessment in areas of sparse
monitoring. International Journal of Geographical Information Science. 2016;30(4):727-47.
26. Zoran MA, Savastru RS, Savastru DM, Tautan MN. Assessing the relationship between surface levels of PM2.5
and PM10 particulate matter impact on COVID-19 in
Milan, Italy. Sci Total Environ. 2020;738:139825.
27. Lee GI, Saravia J, You D, Shrestha B, Jaligama S, Hebert VY, et al. Exposure to combustion generated environmentally persistent free radicals enhances severity
of influenza virus infection. Particle and fibre toxicology. 2014;11(1):1-10.
28. Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, et al. Short-term elevation of fine particulate matter air pollution and acute lower respiratory
infection. American journal of respiratory and critical
care medicine. 2018;198(6):759-66.
29. Lin M, Stieb DM, Chen Y. Coarse particulate matter
and hospitalization for respiratory infections in children younger than 15 years in Toronto: a case-crossover
analysis. Pediatrics. 2005;116(2):e235-e40.
30. Peters JM, Avol E, Navidi W, London SJ, Gauderman
WJ, Lurmann F, et al. A study of twelve Southern California communities with differing levels and types of
air pollution: I. Prevalence of respiratory morbidity.
American journal of respiratory and critical care medicine. 1999;159(3):760-7.
31. Kim K-N, Kim S, Lim Y-H, Song IG, Hong Y-C. Effects
of short-term fine particulate matter exposure on acute
respiratory infection in children. International journal of
hygiene and environmental health. 2020;229:113571.
32. Boldo E, Medina S, Le Tertre A, Hurley F, Mücke H-G,
Ballester F, et al. Apheis: Health impact assessment of
long-term exposure to PM 2.5 in 23 European cities.
European journal of epidemiology. 2006;21(6):449-58.
33. Lambert AL, Trasti FS, Mangum JB, Everitt JI. Effect
of preexposure to ultrafine carbon black on respiratory
syncytial virus infection in mice. Toxicological sciences. 2003;72(2):331-8.
34. Kaan PM, Hegele RG. Interaction between respiratory
syncytial virus and particulate matter in guinea pig alveolar macrophages. American journal of respiratory
cell and molecular biology. 2003;28(6):697-704.
35. Franke-Ullmann G, Pförtner C, Walter P, Steinmüller
C, Lohmann-Matthes M, Kobzik L, et al. Alteration of
pulmonary macrophage function by respiratory syncytial virus infection in vitro. The Journal of Immunology.
1995;154(1):268-80.
36. Croft DP, Zhang W, Lin S, Thurston SW, Hopke PK,
van Wijngaarden E, et al. Associations between sourcespecific particulate matter and respiratory infections in
New York state adults. Environmental Science & Technology. 2019;54(2):975-84.
37. Lall R, Ito K, Thurston GD. Distributed lag analyses of
daily hospital admissions and source-apportioned fine
particle air pollution. Environmental health perspectives. 2011;119(4):455-60.
38. Mishra R, Krishnamoorthy P, Gangamma S, Raut AA,
Kumar H. Particulate matter (PM10) enhances RNA
virus infection through modulation of innate immune
responses. Environmental Pollution. 2020;266:115148.
39. Landguth EL, Holden ZA, Graham J, Stark B, Mokhtari
EB, Kaleczyc E, et al. The delayed effect of wildfire
season particulate matter on subsequent influenza season in a mountain west region of the USA. Environment
International. 2020;139:105668.
40. Magazzino C, Mele M, Schneider N. The relationship
between air pollution and COVID-19-related deaths:
an application to three French cities. Applied Energy.
2020;279:115835.
41. Wu X, Nethery R, Sabath M, Braun D, Dominici F. Air
pollution and COVID-19 mortality in the United States:
Strengths and limitations of an ecological regression
analysis. Science advances. 2020;6(45):eabd4049.
42. Kowalska M, Skrzypek M, Kowalski M, Cyrys J. Effect
of NOx and NO2 concentration increase in ambient air
to daily bronchitis and asthma exacerbation, Silesian
voivodeship in Poland. International Journal of Environmental Research and Public Health. 2020;17(3):754.
43. Ghozikali MG, Heibati B, Naddafi K, Kloog I, Conti
GO, Polosa R, et al. Evaluation of chronic obstructive
pulmonary disease (COPD) attributed to atmospheric
O3, NO2, and SO2 using Air Q Model (2011–2012
year). Environmental research. 2016;144:99-105.
44. Purvis MR, Ehrlich R. Effect of atmospheric pollutants
on susceptibility to respiratory infection: II. Effect of
nitrogen dioxide. The Journal of Infectious Diseases.
1963:72-6.
45. Ciencewicki J, Jaspers I. Air pollution and respiratory viral infection. Inhalation toxicology. 2007;19(14):1135-
46.
46. Becker S, Soukup JM. Effect of nitrogen dioxide on
respiratory viral infection in airway epithelial cells. Environmental research. 1999;81(2):159-66.
47. Ye Q, Fu J-f, Mao J-h, Shang S-q. Haze is a risk factor
contributing to the rapid spread of respiratory syncytial
virus in children. Environmental Science and Pollution
Research. 2016;23(20):20178-85.
48. Bono R, Romanazzi V, Bellisario V, Tassinari R, Trucco G, Urbino A, et al. Air pollution, aeroallergens and
admissions to pediatric emergency room for respiratory reasons in Turin, northwestern Italy. BMC public
health. 2016;16(1):722.
49. Mehta S, Ngo LH, Cohen A, Thach T, Dan VX, Tuan
ND. Air pollution and admissions for acute lower respiratory infections in young children of Ho Chi Minh City.
Air Quality, Atmosphere & Health. 2013;6(1):167-79.
50. Frampton MW, Smeglin AM, Roberts Jr NJ, Finkelstein
JN, Morrow PE, Utell MJ. Nitrogen dioxide exposure
in vivo and human alveolar macrophage inactivation
of influenza virus in vitro. Environmental research.
1989;48(2):179-92.
51. Goings SA, Kulle TJ, Bascom R, Sauder LR, Green
DJ, Hebel JR, et al. Effect of nitrogen dioxide exposure on susceptibility to influenza A virus infection in
healthy adults. American Review of Respiratory Disease. 1989;139(5):1075-81.
52. Zeng W, Zhao H, Liu R, Yan W, Qiu Y, Yang F, et al.
Association between NO2 cumulative exposure and
influenza prevalence in mountainous regions: A case
study from southwest China. Environmental research.
2020;189:109926.
53. Spannhake EW, Reddy SP, Jacoby DB, Yu X-Y, Saatian
B, Tian J. Synergism between rhinovirus infection and
oxidant pollutant exposure enhances airway epithelial
cell cytokine production. Environmental health perspectives. 2002;110(7):665-70.
54. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC,
Marlor CW, et al. The major human rhinovirus receptor
is ICAM-1. Cell. 1989;56(5):839-47.
55. Ogen Y. Assessing nitrogen dioxide (NO2) levels as
a contributing factor to the coronavirus (COVID-19)
fatality rate. Science of The Total Environment.
2020:138605.
56. Filippini T, Rothman KJ, Goffi A, Ferrari F, Maffeis
G, Orsini N, et al. Satellite-detected tropospheric nitrogen dioxide and spread of SARS-CoV-2 infection
in Northern Italy. Science of The Total Environment.
2020;739:140278.
57. Crutzen PJ. The role of NO and NO2 in the chemistry
of the troposphere and stratosphere. Annual review of
earth and planetary sciences. 1979;7(1):443-72.
58. Odman MT, Hu Y, Russell AG, Hanedar A, Boylan JW,
Brewer PF. Quantifying the sources of ozone, fine particulate matter, and regional haze in the Southeastern
United States. Journal of Environmental Management.
2009;90(10):3155-68.
59. Morrison D, Rahman I, MacNee W. Permeability, inflammation and oxidant status in airspace epithelium exposed to ozone. Respiratory medicine.
2006;100(12):2227-34.
60. Mudway IS, Kelly FJ. An investigation of inhaled
ozone dose and the magnitude of airway inflammation
in healthy adults. American journal of respiratory and
critical care medicine. 2004;169(10):1089-95.
61. Pino MV, Levin JR, Stovall MY, Hyde DM. Pulmonary
inflammation and epithelial injury in response to acute
ozone exposure in the rat. Toxicology and applied pharmacology. 1992;112(1):64-72.
62. Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban
communities, 1987-2000. Jama. 2004;292(19):2372-8.
63. Goldberg MS, Burnett RT, Brook J, Bailar III JC, Valois
M-F, Vincent R. Associations between daily causespecific mortality and concentrations of ground-level
ozone in Montreal, Quebec. American journal of epidemiology. 2001;154(9):817-26.
64. Kesic MJ, Meyer M, Bauer R, Jaspers I. Exposure to
ozone modulates human airway protease/antiprotease
balance contributing to increased influenza A infection.
PloS one. 2012;7(4):e35108.
65. Wong TW, Lau TS, Yu TS, Neller A, Wong SL, Tam W,
et al. Air pollution and hospital admissions for respiratory and cardiovascular diseases in Hong Kong. Occupational and environmental medicine. 1999;56(10):679-
83.
66. Jakab GJ, Hmieleski RR. Reduction of influenza virus
pathogenesis by exposure to 0.5 ppm ozone. Journal of
Toxicology and Environmental Health, Part A Current
Issues. 1988;23(4):455-72.
67. Jakab GJ, Bassett DJ. Influenza Virus Infection, Ozone
Exposure, and Fibrogenesis1-3. Am Rev Respir Dis.
1990;141:1307-15.
68. Devlin RB, McDonnell WF, Mann R, Becker S, House
DE, Schreinemachers D, et al. Exposure of humans to
ambient levels of ozone for 6.6 hours causes cellular
and biochemical changes in the lung. Am J Respir Cell
Mol Biol. 1991;4(1):72-81.
69. Balmes J, Aris R, Chen L, Scannell C, Tager I, Finkbeiner W, et al. Effects of ozone on normal and potentially sensitive human subjects. Part I: Airway inflammation and responsiveness to ozone in normal and
asthmatic subjects. Research report (Health Effects Institute). 1997(78):1.
70. Henderson FW, Dubovi EJ, Harder S, ELSTON SEAL
J, Graham D. Experimental Rhinovirus Infection in Human Volunteers Exposed to Ozone1-3. 1988.
71. Zoran MA, Savastru RS, Savastru DM, Tautan MN.
Assessing the relationship between ground levels of
ozone (O3) and nitrogen dioxide (NO2) with coronavirus (COVID-19) in Milan, Italy. Science of The Total
Environment. 2020:140005.
72. Sethi JK, Mittal M. Monitoring the Impact of Air Quality on the COVID-19 Fatalities in Delhi, India: Using
Machine Learning Techniques. Disaster Medicine and
Public Health Preparedness. 2020:1-17.
73. Wu Y, Zhan Q, Zhao Q. Long-term air pollution exposure impact on COVID-19 morbidity in China. Aerosol
and Air Quality Research. 2020.
74. HOLGATE SC. Sulphur Dioxide, Acid Aerosols and
Particulates1992.
75. HORSTMAN DH, SEAL E, FOLINSBEE LJ, IVES P,
ROGER LJ. The relationship between exposure duration and sulfur dioxide-induced bronchoconstriction in
asthmatic subjects. American Industrial Hygiene Association Journal. 1988;49(1):38-47.
76. Sheppard D, Epstein J, Bethel R, Nadel J, Boushey H.
Tolerance to sulfur dioxide-induced bronchoconstriction in subjects with asthma. Environmental research.
1983;30(2):412-9.
77. Ukai K. Effect of SO2 on the pathogenesis of viral
upper respiratory infection in mice. Proceedings of
the Society for Experimental Biology and Medicine.
1977;154(4):591-6.
78. Lebowitz MD, Fairchild GA. The effects of sulfur
dioxide and A2 influenza virus on pneumonia and
weight reduction in mice: An analysis of stimulus-response relationships. Chemico-biological interactions1973;7(5):317-26.
79. Sooryanarain H, Elankumaran S. Environmental role
in influenza virus outbreaks. Annu Rev Anim Biosci.
2015;3(1):347-73.
80. Meng Y, Lu Y, Xiang H, Liu S. Short-term effects of
ambient air pollution on the incidence of influenza in
Wuhan, China: A time-series analysis. Environmental
Research. 2020;192:110327.
81. Zhang D, Li Y, Chen Q, Jiang Y, Chu C, Ding Y, et
al. The relationship between air quality and respiratory
pathogens among children in Suzhou City. Italian journal of pediatrics. 2019;45(1):123.
82. Rodrigues AF, Santos AM, Ferreira AM, Marino R,
Barreira ME, Cabeda JM. Year-long rhinovirus infection is influenced by atmospheric conditions, outdoor
air virus presence, and immune system-related genetic
polymorphisms. Food and environmental virology.
2019;11(4):340-9.
83. World Health Organization. Regional Office for E, Joint
WHOCTFotHAoAP. Health risks of heavy metals from
long-range transboundary air pollution. Copenhagen :
WHO Regional Office for Europe; 2007.
84. Thun MJ, Schnorr TM, Smith AB, Halperin WE, Lemen RA. Mortality among a cohort of US cadmium
production workers—an update. Journal of the National
Cancer Institute. 1985;74(2):325-33.
85. Stayner L, Smith R, Thun M, Schnorr T, Lemen R. A
dose-response analysis and quantitative assessment of
lung cancer risk and occupational cadmium exposure.
Annals of epidemiology. 1992;2(3):177-94.
86. Checconi P, Sgarbanti R, Celestino I, Limongi D, Amatore D, Iuvara A, et al. The environmental pollutant cadmium promotes influenza virus replication in MDCK
cells by altering their redox state. International Journal
of Molecular Sciences. 2013;14(2):4148-62.
87. Bouley G, Chaumard C, Quero A, Girard F, Boudene
C. Opposite effects of inhaled cadmium microparticles
on mouse susceptibility to an airborne bacterial and an
airborne viral infection. Science of The Total Environment. 1982;23:185-8.
88. Chen R, Pan G, Kan H, Tan J, Song W, Wu Z, et al. Ambient air pollution and daily mortality in Anshan, China:
a time-stratified case-crossover analysis. Science of the
total environment. 2010;408(24):6086-91.
89. Gouveia N, Fletcher T. Time series analysis of air pollution and mortality: effects by cause, age and socioeconomic status. Journal of Epidemiology & Community
Health. 2000;54(10):750-5.
90. Woodward NC, Levine MC, Haghani A, Shirmohammadi F, Saffari A, Sioutas C, et al. Toll-like receptor 4 in
glial inflammatory responses to air pollution in vitro and
in vivo. Journal of neuroinflammation. 2017;14(1):84.
Files
IssueVol 5 No 4 (2020): Autumn 2020 QRcode
SectionReview Article(s)
DOI https://doi.org/10.18502/japh.v5i4.6445
Keywords
Air pollution; Upper respiratory infections; Lower respiratory infections; COVID-19; Influenza

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Khajeamiri A, Khajeamiri Y, Sharifi S, Moradpour N. A review on the effect of air pollution and exposure to PM, NO2 , O3 , SO2 , CO and heavy metals on viral respiratory infections. japh. 2021;5(4):243-258.